Blockchain Registration Transaction Record

Neural Therapeutics CEO Ian Campbell Discusses Potential CSE Listing and Future Plans

Neural Therapeutics CEO Ian Campbell discusses the company's conditional approval to list on the Canadian Securities Exchange and the growing interest in psychedelic treatments. This move has the potential to impact mental health treatment and the investment landscape.

Neural Therapeutics CEO Ian Campbell Discusses Potential CSE Listing and Future Plans

The conditional approval for Neural Therapeutics to list on the Canadian Securities Exchange represents a significant opportunity for the company to raise funds, accelerate drug development, and address the growing interest in psychedelic treatments. This move could have a substantial impact on mental health treatment and the investment landscape.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x05abd6fc8f068d34d5a88ead492ecdf1431ea0723138041bce3a14cee665f453
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintdeep67RL-6992b0ff26616ab16c87455e2c973375